Alignment Healthcare CHRO sells 22,238 shares

Alignment Healthcare, Inc. Chief Human Resources Officer Andreas P. Wagner reported a sale of company common stock on a Form 4.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. Chief Human Resources Officer Andreas P. Wagner reported a sale of company common stock on a Form 4. On February 10, 2026, he sold 22,238 shares of common stock at $20.47 per share and held 169,805 shares afterward, all directly owned.

According to the footnote, these shares were sold solely to cover tax withholding obligations arising from the vesting of restricted share units. The filing states this was not a discretionary trade by the reporting person, indicating the sale was linked to equity compensation rather than an open-market portfolio decision.

Insider Trade Summary

Net Seller: 22,238 shares

Net Sell 1 txn

Insider Wagner Andreas P.

Role Chief Human Resources Officer

Sold 22,238 shs ($455K)

Type	Security	Shares	Price	Value
Sale	Common Stock	22,238	$20.47	$455K

Holdings After Transaction: Common Stock — 169,805 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This transaction does not represent a discretionary trade by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ALHC report for Andreas P. Wagner?

Alignment Healthcare reported that Chief Human Resources Officer Andreas P. Wagner sold 22,238 shares of common stock on February 10, 2026, at $20.47 per share. The Form 4 shows this was linked to equity compensation tax withholding, not a discretionary trading decision.

Why did the Alignment Healthcare (ALHC) CHRO sell 22,238 shares?

The 22,238 shares were sold to cover tax withholding obligations from the vesting of restricted share units. The filing explicitly notes the transaction does not represent a discretionary trade by Andreas P. Wagner, indicating it was driven by tax requirements on equity compensation.

How many ALHC shares does Andreas P. Wagner own after this Form 4 sale?

After the reported transaction, Andreas P. Wagner beneficially owns 169,805 shares of Alignment Healthcare common stock. The Form 4 lists this amount as directly owned, following the sale of 22,238 shares to satisfy tax withholding on vested restricted share units.

What was the sale price in the latest ALHC insider transaction?

The reported sale price was $20.47 per share for Alignment Healthcare common stock. Chief Human Resources Officer Andreas P. Wagner sold 22,238 shares at this price on February 10, 2026, specifically to cover tax withholding obligations from restricted share unit vesting.

Is the ALHC insider sale by Andreas P. Wagner considered discretionary trading?

No, the filing states the transaction does not represent a discretionary trade. The shares were sold automatically to cover tax withholding associated with the vesting of restricted share units, meaning the sale was driven by compensation-related obligations rather than an elective trading decision.

What role does Andreas P. Wagner hold at Alignment Healthcare (ALHC)?

Andreas P. Wagner serves as Chief Human Resources Officer at Alignment Healthcare, Inc. His position is identified in the Form 4, which reports his sale of 22,238 common shares to satisfy tax withholding obligations related to the vesting of restricted share units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 09:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagner Andreas P.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		S		22,238(1)	D	$20.47	169,805	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This transaction does not represent a discretionary trade by the reporting person.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Andreas P. Wagner	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.